CIM
GILD icon

Contrarius Investment Management’s Gilead Sciences GILD Stock Holding History

Contrarius Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-142,465
Closed -$8.91M – 48
2018
Q4 		$8.91M Sell
142,465
-46,433
-25% -$3.25M 0.54% 32
2018
Q3 		$14.6M Buy
188,898
+19,139
+11% +$1.45M 0.65% 29
2018
Q2 		$12M Buy
169,759
+13,272
+8% +$937K 0.47% 33
2018
Q1 		$11.8M Sell
156,487
-54,808
-26% -$4.36M 0.56% 33
2017
Q4 		$15.1M Sell
211,295
-586,192
-74% -$44.5M 0.75% 29
2017
Q3 		$64.6M Sell
797,487
-273,244
-26% -$20.9M 3.78% 10
2017
Q2 		$75.8M Buy
1,070,731
+165,866
+18% +$11M 5.07% 8
2017
Q1 		$61.5M Buy
904,865
+871,721
+2,630% +$61.3M 3.95% 9
2016
Q4 		$2.37M Sell
33,144
-229,620
-87% -$17.1M 0.18% 41
2016
Q3 		$20.8M Buy
+262,764
New +$21.3M 1.53% 17
2016
Q2 		– Sell
-62,288
Closed -$5.72M – 54
2016
Q1 		$5.72M Buy
62,288
+4,691
+8% +$423K 0.51% 34
2015
Q4 		$5.83M Buy
57,597
+708
+1% +$73.7K 0.55% 35
2015
Q3 		$5.59M Buy
+56,889
New +$6.32M 0.55% 30

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Contrarius Investment Management's GILD Position: Q1 2019 in Review

Contrarius Investment Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 142,465 shares — an estimated $8.91M sold.

Contrarius Investment Management first reported a position in GILD in Q3 2015 and held it in 13 quarters. The position peaked at $75.8M in Q2 2017. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Contrarius Investment Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Contrarius Investment Management sold 142,465 Gilead Sciences shares in Q1 2019, an estimated $8.91M.
  • Contrarius Investment Management first reported a position in Gilead Sciences in Q3 2015 and held it in 13 quarters.
  • Contrarius Investment Management's Gilead Sciences position peaked at $75.8M in Q2 2017.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Contrarius Investment Management's 13F filing for Q1 2019, filed 8 May 2019.